Pancreatic Tumors

Pancreatic Tumors

Virginia Surgery Associates offers a comprehensive Pancreatic Cancer Screening Program to:

  • Reduce risk and implement prevention strategies
  • Identify and offer early detection of pancreatic cancer in high risk patients
  • Offer early treatment options once diagnosed thus improving survival from the disease

Our Program Includes:

  • A multidisciplinary team who works together to assess an individual’s risk of developing pancreatic cancer
  • Regular evaluations, genetic counseling, and for patients who are deemed to be high risk; annual monitoring byradiologic studies such as an MRI or Ultrasound (EUS) of the pancreas

Pancreatic Cancer Facts

  • Pancreatic cancer accounts for about 3% of all cancers and 7% of all cancer deaths in the U.S.
  • The average lifetime risk for pancreatic cancer is 1.5% (or 1 in 63) among men and women
  • By the end of 2018, 55,440 people in the U.S. were diagnosed with pancreatic cancer and 44,300 will die of the disease
  • It is the fourth leading cause of cancer deaths
  • Early detections and multi-modality treatment improve survival

Who is at risk?

    • NCCN guidelines suggest genetic testing for any pancreatic cancer patient as of 2018
    • Certain genetic syndromes and a family history of pancreatic cancer
    • Hereditary syndromes include: Breast and Ovarian Cancer Syndrome, Hereditary Colon Cancer (HNPCC), Familial Atypical Multiple Mole Melanoma, Peutz-Jeghers Syndrome, BRCA 1 and 2 patients
    • Two or more first degree relatives or three or more any relative with a pancreatic cancer diagnosis

    For more information or to schedule an appointment with our Pancreatic Cancer Screening Program, please call (703) 359-8640.